tetano
Editor, Senior Moderator
Emerg Infect Dis
. 2023 Mar 27;29(5).
doi: 10.3201/eid2905.221541. Online ahead of print.
SARS-CoV-2 Seroprevalence Compared with Confirmed COVID-19 Cases among Children, Colorado, USA, May-July 2021
Shannon C O'Brien, Lyndsey D Cole, Bernadette A Albanese, Allison Mahon, Vijaya Knight, Nathan Williams, Rachel Severson, Alexis Burakoff, Nisha B Alden, Samuel R Dominguez
Abstract
To compare SARS-CoV-2 antibody seroprevalence among children with seropositive confirmed COVID-19 case counts (case ascertainment by molecular amplification) in Colorado, USA, we conducted a cross-sectional serosurvey during May-July 2021. For a convenience sample of 829 Colorado children, SARS-CoV-2 seroprevalence was 36.7%, compared with prevalence of 6.5% according to individually matched COVID-19 test results reported to public health. Compared with non-Hispanic White children, seroprevalence was higher among Hispanic, non-Hispanic Black, and non-Hispanic other race children, and case ascertainment was significantly lower among Hispanic and non-Hispanic Black children. This serosurvey accurately estimated SARS-CoV-2 prevalence among children compared with confirmed COVID-19 case counts and revealed substantial racial/ethnic disparities in infections and case ascertainment. Continued efforts to address racial and ethnic differences in disease burden and to overcome potential barriers to case ascertainment, including access to testing, may help mitigate these ongoing disparities.
Keywords: 2019 novel coronavirus disease; 2019 novel coronavirus infection; 2019-nCoV; COVID-19; Colorado; SARS-CoV-2; SARS-CoV-2 infection; United States; antibody testing; coronavirus disease; diagnostic testing; pandemic; respiratory infections; serologic testing; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.
. 2023 Mar 27;29(5).
doi: 10.3201/eid2905.221541. Online ahead of print.
SARS-CoV-2 Seroprevalence Compared with Confirmed COVID-19 Cases among Children, Colorado, USA, May-July 2021
Shannon C O'Brien, Lyndsey D Cole, Bernadette A Albanese, Allison Mahon, Vijaya Knight, Nathan Williams, Rachel Severson, Alexis Burakoff, Nisha B Alden, Samuel R Dominguez
- PMID: 36972709
- DOI: 10.3201/eid2905.221541
Abstract
To compare SARS-CoV-2 antibody seroprevalence among children with seropositive confirmed COVID-19 case counts (case ascertainment by molecular amplification) in Colorado, USA, we conducted a cross-sectional serosurvey during May-July 2021. For a convenience sample of 829 Colorado children, SARS-CoV-2 seroprevalence was 36.7%, compared with prevalence of 6.5% according to individually matched COVID-19 test results reported to public health. Compared with non-Hispanic White children, seroprevalence was higher among Hispanic, non-Hispanic Black, and non-Hispanic other race children, and case ascertainment was significantly lower among Hispanic and non-Hispanic Black children. This serosurvey accurately estimated SARS-CoV-2 prevalence among children compared with confirmed COVID-19 case counts and revealed substantial racial/ethnic disparities in infections and case ascertainment. Continued efforts to address racial and ethnic differences in disease burden and to overcome potential barriers to case ascertainment, including access to testing, may help mitigate these ongoing disparities.
Keywords: 2019 novel coronavirus disease; 2019 novel coronavirus infection; 2019-nCoV; COVID-19; Colorado; SARS-CoV-2; SARS-CoV-2 infection; United States; antibody testing; coronavirus disease; diagnostic testing; pandemic; respiratory infections; serologic testing; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.